Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 77.83B | 17.6x | -1.14 | ZAC 17,521 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.1% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.22B | 12.6x | ZAC 8,593 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.22B | 12.6x | 0.76 | ZAC 1,380 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Adcock Ingram Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 9.54B | 12x | -2.98 | ZAC 6,500 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.8% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | ZAR 494.34M | 8.6x | -0.48 | ZAC 79 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 306.80M | 253.5x | ZAC 432 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 168.69M | 5.4x | 0.01 | ZAC 1,544 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.9% Upside | Upgrade to Pro+ |